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SHORT TAKE
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Summary
Human longevity is characterized by a remarkable lack of
confirmed genetic associations. Here, we report on the identifi-
cation of a novel locus for longevity in the RAD50/IL13 region on
chromosome 5q31.1 using a combined European sample of 3208
long-lived individuals (LLI) and 8919 younger controls. First, we
performed a large-scale association study on 1458 German LLI
(mean age 99.0 years) and 6368 controls (mean age 57.2 years) by
targeting known immune-associated loci covered by the Immu-
nochip. The analysis of 142 136 autosomal single nucleotide
polymorphisms (SNPs) revealed an Immunochip-wide significant
signal (PImmunochip = 7.01 3 10
–9) for the SNP rs2075650 in the
TOMM40/APOE region, which has been previously described in
the context of human longevity. To identify novel susceptibility
loci, we selected 15 markers with PImmunochip < 5 3 10
–4 for
replication in two samples from France (1257 LLI, mean age
102.4 years; 1811 controls, mean age 49.1 years) and Denmark
(493 LLI, mean age 96.2 years; 740 controls, mean age 63.1 years).
The association at SNP rs2706372 replicated in the French study
collection and showed a similar trend in the Danish participants
and was also significant in a meta-analysis of the combined
French and Danish data after adjusting for multiple testing. In a
meta-analysis of all three samples, rs2706372 reached a P-value of
PImmunochip+Repl = 5.42 3 10
7 (OR = 1.20; 95% CI = 1.12–1.28).
SNP rs2706372 is located in the extended RAD50/IL13 region.
RAD50 seems a plausible longevity candidate due to its involve-
ment in DNA repair and inflammation. Further studies are needed
to identify the functional variant(s) that predispose(s) to a long
and healthy life.
Key words: 5q31.1; genetic association; human longevity;
IL13; Immunochip; RAD50.
Despite more than 20 years of research into the genetic basis of human
longevity, only alleles in the APOE and FOXO3 genes have repeatedly
been shown to be associated with survival to very advanced ages
(Sch€achter et al., 1994; Willcox et al., 2008; Flachsbart et al., 2009;
Soerensen et al., 2010; Deelen et al., 2013). APOE and FOXO3 were
initially detected in candidate-driven case–control investigations, but
APOE has since then been confirmed in a number of genome-wide
association studies (GWAS). In addition, a single nucleotide polymor-
phism (SNP) on chromosome 5q33.3 was recently identified in a GWAS
meta-analysis on long-lived individuals (LLI) aged ≥ 90 years (Deelen
et al., 2014). Besides the detection of APOE and the 5q33.3 locus,
longevity GWAS have been relatively unsuccessful and have failed to
reveal novel associations with genome-wide significance or sufficient
reproducibility (Deelen et al., 2011, 2014; Nebel et al., 2011). Here, we
performed a large-scale candidate gene study by targeting established
immune-associated loci present on the Immunochip (Trynka et al.,
2011). The Immunochip was designed to perform fine-mapping of
GWAS loci of major immune-mediated diseases using data from the
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1000 Genomes Project and other sequencing initiatives. The application
of the array in this study is based on the hypothesis that a well-
functioning immune system and efficient anti-inflammatory networks
are potent longevity-assurance mechanisms (Franceschi et al., 2007).
We employed the Immunochip to screen 1458 German LLI and 6368
younger controls in a discovery phase (panel A in Table S1) for novel
longevity loci followed by replication in 1750 LLI and 2551 younger
controls from France and Denmark (panel B in Table S1).
After applying conservative and established quality filters to the
German longevity sample, 142 136 autosomal SNPs were available for
association analysis (see Appendix S1). We used a predefined threshold
of P = 6.15 9 107 to define statistical significance for the Immuno-
chip-wide analysis, based on the Bonferroni correction for the number of
linkage disequilibrium (LD)-independent markers on the Immunochip
(see Appendix S1). The comparison of the case–control frequencies
yielded an Immunochip-wide significant association signal for the SNP
rs2075650 in the TOMM40/APOE region (PImmunochip = 7.01 9 10
9;
OR = 0.69; 95% CI = 0.60–0.78; Table 1, Figs S1 and S2a). This SNP is
in moderate LD (r2 = 0.52) with SNP rs429358 that defines the well-
established APOE e4 allele (Deelen et al., 2011), and hence, rs2075650
was not considered for replication. With regard to the FOXO3 and the
5q33.3 loci, the Immunochip is uninformative due to poor coverage
(Fig. S2b,c). Eighty-four other SNPs showed PImmunochip < 5 9 10
4 in
the discovery Immunochip analysis (Table S2). Of these, we selected 15
markers for replication, each one representing the best SNP for a specific
associated region defined by the clumping procedure (see Appendix S1,
Table S3). The replication analysis was performed in two longevity
samples from France and Denmark (France: 1257 LLI and 1811 controls;
Denmark: 493 LLI and 740 controls; panel B in Table S1). The signal at
SNP rs2706372, located in a region encompassing RAD50 (radiation
sensitive, Saccharomyces cerevisiae homolog) and IL13 (Interleukin 13),
replicated in the French sample (PRepl-France = 2.69 9 10
3; OR = 1.21;
95% CI = 1.07–1.38; PRepl-France; adj = 0.04 (corrected for 15 tests))
(Table S4). In the smaller Danish sample, the allelic effect of rs2706372
showed a similar trend (PRepl-Denmark = 0.08; OR = 1.19; 95%
CI = 0.98–1.45; PRepl-Denmark; adj = 1 (corrected for 15 tests)). In the
combined French-Danish replication sample, meta-analysis association
analysis yielded a P-value of 4.95 9 104 (OR = 1.21; 95% CI = 1.09–
1.34; PRepl-France-Denmark; adj = 0.0074 (corrected for 15 tests)). In a meta-
analysis of the German discovery and French-Danish replication samples,
rs2706372 reached a P-value of PImmunochip+Repl = 5.42 9 10
7
(Table 1). Estimates of odds ratios for rs2706372 were consistent across
all three studies (ORGermany = 1.19; ORDenmark = 1.19; ORFrance = 1.21;
statistical metric of heterogeneity I2 = 0.0), supporting the validity of the
association finding.
Our targeted immune gene approach on a combined European
sample of 3208 LLI and 8919 controls resulted in the identification of a
novel association for longevity in the RAD50/IL13 region on chromo-
some 5q31.1. The lead SNP rs2706372 is located in the intronic region
of the RAD50 gene and is in strong LD with other associated SNPs close
to IL13 and IL5. The actual association signal extends even further to
include additional genes (Fig. 1). At this point, this observation renders
it difficult to assess which gene is actually affected by the association,
although RAD50 is a plausible candidate. The protein encoded by
RAD50 is highly similar to Saccharomyces cerevisiae Rad50 which is
involved in repairing DNA double-strand breaks. Similarly, the human
RAD50 is integrated in a functional DNA-binding complex (Kinoshita
et al., 2015) that is important for recombination, repair, and genomic
stability (Trujillo et al., 1998). Hence, it is conceivable that variation in
RAD50 could positively influence longevity by increasing DNA stability. Ta
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Alternatively, it could exert its effect via the direct modulation of
cytokine expression; recent evidence suggests at least two possible
avenues. First, in dendritic cells RAD15 was found to activate—upon
sensing viral DNA—the transcription factor NF-jB, thus leading to the
production of pro-inflammatory IL-1b (Roth et al., 2014). Second, the
RAD50 gene harbors at its 3’ end an evolutionarily highly conserved
locus control region (LCR; Lee et al., 2003; Li et al., 2010) that regulates
the expression of the neighboring cytokine genes IL-4, IL-13, and IL-5
(Fig. 1) in Th2 cells (Kelly & Locksley, 2000). Variants in the LCR were
found to be associated with asthma (Li et al., 2010). Taken together,
these findings indicate that the RAD50 locus may very well contribute to
longevity via its role in inflammation and immunity. Nevertheless, it is still
possible that the RAD50 signal is a result of its LD with other markers
within the observed association boundaries. Multiple SNPs in the
extended RAD50/IL13 region were previously identified as susceptibility
factors for various chronic inflammatory diseases such as Crohn’s
disease, psoriasis, asthma, and atopic dermatitis (Rioux et al., 2000; Li
et al., 2008, 2010; Paternoster et al., 2011). Further studies are
therefore needed to identify the functional variant(s) and the underlying
molecular mechanisms that predispose(s) to a long and healthy life.
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